EPR Cancer Research Results
EPR, enhanced permeability and retention (EPR) effect: Click to Expand ⟱
| Source: |
| Type: |
Passive accumulation (in cells) is based on the unique architecture of the tumor tissue, where neo-angiogenesis leads to an atypical endothelial layer and to fenestrated vasculature, which together with the impaired lymphatic drainage guides the penetration and accumulation of nano-sized materials within the cancerous tissues.
Exploited for drug design in the nanomedicine field.
|
BC, Breast Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vivo, |
BC, |
MDA-MB-231 |
|
|
|
antiNeop↑, CSCsMark↓, CD44↓, SOX2↓, HIF-1↓, VEGF↓, Dose↝, Dose↝, EPR↝, PPARγ↑,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Core Metabolism/Glycolysis(tgid=4) ⓘ
PPARγ↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CD44↓, 1, CSCsMark↓, 1, SOX2↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
EPR↝, 1, HIF-1↓, 1, VEGF↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
Dose↝, 2,
Functional Outcomes(tgid=23) ⓘ
antiNeop↑, 1,
Total Targets: 9
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: EPR, enhanced permeability and retention (EPR) effect
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:4 Cells:% prod#:% Target#:612 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page